Delving into the Latest Updates on THPharm with Synapse

概览

关联

4

项与 THPharm 相关的临床试验

TCTR20241006001 / Not yet recruiting临床3期

A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 clinical trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects with T2DM and Essential Hypertension

开始日期2024-12-31

申办/合作机构

THPharm

NCT06647745 / Not yet recruiting临床3期

A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

[Primary Objective] To demonstrate the superiority of the change in mean sitting systolic blood pressure (MSSBP) and hemoglobin A1c (HbA1c)on week 12 of the combination therapy of THP-00101 (dapagliflozin 10 mg) and THP-00102 (telmisartan 80 mg) compared to THP-00101 or THP-00102 monotherapy among subjects with type 2 diabetes mellitus accompanied by essential hypertension. [Secondary Objective] To comparatively evaluate secondary efficacy and safety in the THP-00101 monotherapy group, THP-00102 monotherapy group, THP-00101 and THP-00102 combination therapy group, and THP-00101 and THP-00103 (telmisartan 40 mg) combination therapy group among subjects with type 2 diabetes mellitus accompanied by essential hypertension.

开始日期2024-12-01

申办/合作机构

THPharm

NCT06063109 / Completed临床1期

A Two-arm, Open-label, Single-sequence, Multiple Oral Dosings, Crossover Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of THP-00101 and THP-00102 in Healthy Adult Volunteers

The study was designed to evaluate the safety and pharmacokinetic interaction between THP-00101 and THP-00102 in healthy adult volunteers.

开始日期2023-10-09

申办/合作机构

THPharm

100 项与 THPharm 相关的临床结果

登录后查看更多信息

0 项与 THPharm 相关的专利（医药）

登录后查看更多信息

100 项与 THPharm 相关的药物交易

登录后查看更多信息

100 项与 THPharm 相关的转化医学

登录后查看更多信息